Caritas Neuro Solutions announces collaboration with Drug Science to advance the development of medicinal cannabis and psychedelics through clinical trials

[Edinburgh, UK, 18th May 2023] – Caritas Neuro Solutions, a leading provider of clinical research services for neurology and psychedelic trials, has announced a collaboration with Drug Science Ltd., a non-profit organisation dedicated to drug policy reform and research in the field of medicinal cannabis, psychedelics, and recreational drugs. The collaboration will support Drug Science and Drug Science’s partners who wish to develop their drug pipeline with human trials.

 

The collaboration aims to advance the development of medicinal cannabis and psychedelics through clinical trials, by leveraging Caritas Neuro Solutions’ clinical trial management expertise and Drug Science’s scientific knowledge and contacts in the field. Under the agreement, Caritas Neuro Solutions will provide comprehensive clinical trial management services to support the clinical studies of Drug Science and their partners. This will include but is not limited to study design, regulatory support, and operational expertise.

 

“We are proud to collaborate with this fantastic charity to advance the development of medicinal cannabis and psychedelics through clinical trials,” said Leigh Fell, CEO of Caritas Neuro Solutions. “Our clinical trial management expertise combined with Drug Science’s scientific knowledge will enable us to accelerate research in this important field and ultimately benefit patients.”

 

Drug Science: “We are delighted to have our new collaboration with Caritas Neuro Solutions, and excited as it opens up new possibilities in our clinical trials work. We hope that together we can advance and accelerate the development of medical cannabis and psychedelics!”

 

About Caritas Neuro Solutions:

Caritas Neuro Solutions is a leading provider of clinical research services for neurology and psychedelic trials in the UK. The company offers comprehensive clinical trial management and regulatory support services to pharmaceutical and biotechnology companies, academic institutions, and non-profit organisations.

 

Elliot Taylor

Business Development & Clinical Research Associate

On behalf of Caritas Neuro Solutions

A division of Caritas Science Solutions

Share this post